Products
Research Areas
COVID-19
Resources
Login
Quick Order
Cart Cart lightblue
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Contact Us

Location


Corporate Headquarters

Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States

Telephone Numbers



Customer Service: (800) 227-6666 / (650) 697-3600


Contact Us



Additional Contact Details

Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.


Fields marked with a * are required.

Login
Quick Order
Catalog Number Size Price
LS-C755416-50 50 µl (1 mg/ml) $303 
LS-C755416-100 100 µl (1 mg/ml) $365 
CBR / CBR1 Antibody - ICC/IF analysis of CBR1 in HeLa cells line, stained with DAPI (Blue) for nucleus staining and monoclonal anti-human CBR1 antibody (1:100) with goat anti-mouse IgG-Alexa fluor 488 conjugate (Green).
CBR / CBR1 Antibody - The Recombinant Human CBR1 (50ng) and Cell lysates (40ug) were resolved by SDS-PAGE, transferred to PVDF membrane and probed with anti-human CBR1 antibody (1:1000). Proteins were visualized using a goat anti-mouse secondary antibody conjugated to HRP and an ECL detection system. Lane 1.: Recombinant Human CBR1 Lane 2. : HeLa cell lysate Lane 3. : 293T cell lysate Lane 4. : MCF-7 cell lysate Lane 5. : HepG2 cell lysate
CBR / CBR1 Antibody - ICC/IF analysis of CBR1 in HeLa cells line, stained with DAPI (Blue) for nucleus staining and monoclonal anti-human CBR1 antibody (1:100) with goat anti-mouse IgG-Alexa fluor 488 conjugate (Green).
CBR / CBR1 Antibody - The Recombinant Human CBR1 (50ng) and Cell lysates (40ug) were resolved by SDS-PAGE, transferred to PVDF membrane and probed with anti-human CBR1 antibody (1:1000). Proteins were visualized using a goat anti-mouse secondary antibody conjugated to HRP and an ECL detection system. Lane 1.: Recombinant Human CBR1 Lane 2. : HeLa cell lysate Lane 3. : 293T cell lysate Lane 4. : MCF-7 cell lysate Lane 5. : HepG2 cell lysate
1 of 2
2 of 2

Monoclonal Mouse anti‑Human CBR / CBR1 Antibody (clone AT2D6, WB) LS‑C755416

Monoclonal Mouse anti‑Human CBR / CBR1 Antibody (clone AT2D6, WB) LS‑C755416

Antibody:
CBR / CBR1 Mouse anti-Human Monoclonal (AT2D6) Antibody
Application:
ICC, WB, Flo, ELISA
Reactivity:
Human
Format:
Unconjugated, Unmodified
Price
Catalog Number
$303
LS-C755416-50
Toll Free North America
(800) 227-6666
For Research Use Only

Overview

Antibody:
CBR / CBR1 Mouse anti-Human Monoclonal (AT2D6) Antibody
Application:
ICC, WB, Flo, ELISA
Reactivity:
Human
Format:
Unconjugated, Unmodified

Specifications

Description
CBR1 antibody LS-C755416 is an unconjugated mouse monoclonal antibody to human CBR1 (CBR). Validated for ELISA, Flow, ICC and WB.
Target
Human CBR / CBR1
Synonyms
CBR1 | Carbonyl reductase 1 | Carbonyl reductase (NADPH) 1 | HCBR1 | Prostaglandin 9-ketoreductase | SDR21C1 | Carbonyl reductase [NADPH] 1 | CBR | CRN | Prostaglandin-E(2) 9-reductase
Host
Mouse
Reactivity
Human (tested or 100% immunogen sequence identity)
Clonality
IgG2a,k Monoclonal
Clone
AT2D6
Conjugations
Unconjugated
Purification
Protein A affinity chromatography
Modifications
Unmodified
Immunogen
Recombinant human CBR1 (1-277aa) purified from E. coli
Applications
  • ICC (1:100)
  • Western blot (1:1000)
  • Flow Cytometry
  • ELISA
Usage
Applications should be user optimized.
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 10% Glycerol
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
About CBR / CBR1
P16152 NM_001757 NP_001748.1

Publications (0)

Customer Reviews (0)


Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at:

Technical.Support@LSBio.com

Requested From: United States
Date Requested: 11/16/2024